Autumn portrait of happy girl on a walk

F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer

Start

In a key clinical trial, patients who got the pill, daraxonrasib, lived twice as long as those who got chemotherapy.

Previous Story

Meta to Pay Up to $17.1 Billion in Landmark Settlement Over Social Media Addiction Claims

Next Story

Some Scientists Have ‘Magic Hands’ in the Lab. This A.I. Is Learning Why.